Miglustat for treatment of Niemann-Pick C disease: a randomised

Por um escritor misterioso

Descrição

Miglustat for treatment of Niemann-Pick C disease: a randomised
Inhibition of Histone Deacetylases 1, 2, and 3 Enhances Clearance of Cholesterol Accumulation in Niemann-Pick C1 Fibroblasts
Miglustat for treatment of Niemann-Pick C disease: a randomised
Full article: New therapies in the management of Niemann-Pick type C disease: clinical utility of miglustat
Miglustat for treatment of Niemann-Pick C disease: a randomised
IJMS, Free Full-Text
Miglustat for treatment of Niemann-Pick C disease: a randomised
Unbiased yeast screens identify cellular pathways affected in Niemann–Pick disease type C
Miglustat for treatment of Niemann-Pick C disease: a randomised
Ocular motor biomarkers in Niemann-Pick disease type C: A prospective cross-sectional multicontinental study in 72 patients
Miglustat for treatment of Niemann-Pick C disease: a randomised
Recent advances in the treatment of Niemann pick disease type C: A mini-review - ScienceDirect
Miglustat for treatment of Niemann-Pick C disease: a randomised
Miglustat in patients with Niemann-Pick disease Type C (NP-C): A
Miglustat for treatment of Niemann-Pick C disease: a randomised
Recommendations for the detection and diagnosis of Niemann-Pick disease type C
Miglustat for treatment of Niemann-Pick C disease: a randomised
Identification of Niemann-Pick C1 disease biomarkers through sphingolipid profiling - ScienceDirect
Miglustat for treatment of Niemann-Pick C disease: a randomised
Treatment outcomes following continuous miglustat therapy in patients with Niemann-Pick disease Type C: a final report of the NPC Registry, Orphanet Journal of Rare Diseases
de por adulto (o preço varia de acordo com o tamanho do grupo)